Human TSG101 does not replace Saccharomyces cerevisiae VPS23 role in the quality control of plasma membrane proteins

FEMS Microbiology Letters

Volumn 221, Issue 2, 2003, Pages 151-154

  Blanco, Sandra ^a   Lazo, Pedro A ^a  

^a CSIC   (Spain)

Author keywords

Quality membrane protein; STP22; TSG101; VPS23

Indexed keywords

ARGININE PERMEASE; MATING HORMONE ALPHA FACTOR; MEMBRANE PROTEIN; PERMEASE; UNCLASSIFIED DRUG; FUNGAL PROTEIN; MUTANT PROTEIN; PROTEIN VPS23; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ARTICLE; CELL MEMBRANE; CELL MOTILITY; CELL VACUOLE; COMPARATIVE STUDY; CONTROLLED STUDY; FUNGAL GENE; FUNGUS MUTANT; GENE FUNCTION; GENE ISOLATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; SACCHAROMYCES CEREVISIAE; TUMOR CELL; PROTEIN DEFECT;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0037432702     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00179-4     Document Type: Article

References (16)

1. Babst M., Odorizzi G., Estepa E.J., Emr S.D. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 1:2000;248-258.
2. Katzmann D.J., Odorizzi G., Emr S.D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell. Biol. 3:2002;893-905.
3. Bishop N., Woodman P. TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J. Biol. Chem. 276:2001;11735-11742.
4. Bishop N., Horman A., Woodman P. Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. J. Cell. Biol. 157:2002;91-102.
5. Li Y., Kane T., Tipper C., Spatrick P., Jenness D.D. Yeast mutants affecting possible quality control of plasma membrane proteins. Mol. Cell. Biol. 19:1999;3588-3599.
6. Li L., Cohen S.N. tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 85:1996;315-329.
7. Ponting C.P., Cai Y.D., Bork P. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. 75:1997;467-469.
8. Pornillos O., Alam S.L., Rich R.L., Myszka D.G., Davis D.R., Sundquist W.I. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21:2002;2397-2406.
9. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl. Acad. Sci. USA. 98:2001;7724-7729.
10. Ruland J., Sirard C., Elia A., MacPherson D., Wakeham A., Li L., Luis De La Pompa J., Cohen S.N., Mak T.W. p53 Accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc. Natl. Acad. Sci. USA. 98:2001;1859-1864.
11. Oh H., Mammucari C., Nenci A., Cabodi S., Cohen S.N., Dotto G.P. Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1. Proc. Natl. Acad. Sci. USA. 99:2002;5430-5435.
12. Lee M.P., Feinberg A.P. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res. 57:1997;3131-3134.
13. Wang Q., Driouch K., Courtois S., Champeme M.H., Bieche I., Treilleux I., Briffod M., Rimokh R., Magaud J.P., Curmi P., Lidereau R., Puisieux A. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers. Oncogene. 16:1998;677-679.
14. Ferrer M., Lopez-Borges S., Lazo P.A. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines. Oncogene. 18:1999;2253-2259.
15. Ferrer M., Hernandez S., Campo E., Lazo P.A. Loss of the TSG101 leucine zipper domain in aggressive non-Hodgkin's lymphomas. Leukemia. 14:2000;2014-2016.
16. Hochstrasser M., Ellison M.J., Chau V., Varshavsky A. The short-lived MAT alpha 2 transcriptional regulator is ubiquitinated in vivo. Proc. Natl. Acad. Sci. USA. 88:1991;4606-4610.